Differential long-term and multilineage engraftment potential from subfractions of human CD34+cord blood cells transplanted into NOD/SCID mice
- 8 January 2002
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 99 (1) , 413-418
- https://doi.org/10.1073/pnas.012336799
Abstract
Over the past decade xenotransplantation systems have been used with increasing success to gain a better understanding of human cells that are able to initiate and maintain the hematopoietic systemin vivo. The nonobese diabetic/severe combined immunodeficiency (SCID) mouse has been a particularly useful model. Human cells capable of hematopoietic repopulation in this mouse, termed SCID-repopulating cells, have been assumed to represent the most primitive elements of the hematopoietic system, responsible for long-term maintenance of hematopoiesis. However, we demonstrate that SCID-repopulating cells present in the CD34+cell fraction of cord blood can be segregated into subpopulations with distinct repopulation characteristics. CD34+/CD38+progenitors can repopulate recipients rapidly, but can only maintain the graft for 12 weeks or less and have no secondary repopulation potential. Conversely, the more primitive CD34+/CD38−subpopulation repopulates recipients more gradually, can maintain the graft for at least 20 weeks, and contains cells with serial repopulation potential throughout the engraftment period. Additionally, a much higher frequency of T cell precursors are found among SCID-repopulating cells in the CD34+/CD38−subpopulation. These findings demonstrate that cells with variable repopulation potential comprise the human CD34+population and that short- and long-term potential of human precursors can be evaluated in the mouse model.Keywords
This publication has 54 references indexed in Scilit:
- Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-β2 microglobulin–null miceJournal of Clinical Investigation, 2001
- A Defined Window for Efficient Gene Marking of Severe Combined Immunodeficient-Repopulating Cells Using a Gibbon Ape Leukemia Virus-Pseudotyped Retroviral VectorHuman Gene Therapy, 2000
- The Biology of Hematopoietic Stem CellsAnnual Review of Cell and Developmental Biology, 1995
- Human CD8 transgene regulation of HLA recognition by murine T cells.The Journal of Experimental Medicine, 1995
- Engraftment of immune-deficient mice with primitive hematopoietic cells from β-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocolsHuman Molecular Genetics, 1995
- Phenotypic analysis of murine long-term hemopoietic reconstituting cells quantitated competitively in vivo and comparison with more advanced colony-forming progeny.The Journal of Experimental Medicine, 1995
- The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotypeImmunity, 1994
- CD45 isoform expression on human haemopoietic cells at different stages of developmentBritish Journal of Haematology, 1994
- Hematopoietic stem cellsCurrent Opinion in Immunology, 1992
- Life span of multipotential hematopoietic stem cells in vivo.The Journal of Experimental Medicine, 1990